Tuesday, April 25, 2017

Needle-Free Diabetes Management Market Size, Share, Development and Demand Forecast to 2025

Needle Free Diabetes Management Market
The study suggests that the global needle free diabetes management market is likely to grow from $3,830.6 million in 2016 to $16.8 billion by 2025. With the explosive growth of needle-free treatment devices and the increasing awareness regarding the safety issues associated with needles, the needle-free diabetes management market is gaining traction. The growing need for development of safe needle-free diagnostic device has fueled the demand for continuous blood glucose monitoring across all regions worldwide.

Browse the Report Summary at: http://bit.ly/2p2W6Ky

Insights on market segments

As per the findings of research, the artificial pancreas market is expected to witness the fastest growth during 2017 – 2025 and needle-free diabetes treatment devices have been the largest revenue generator for the global market.

North America stand as the largest needle-free diabetes management market

Geographically, North America has been the largest market for needle-free diabetes management devices, with an estimated 41.5% contribution to the global market in 2016. Globally, The U.S. had been the largest country for needle-free diabetes management devices in 2016 and it is expected to continue being the largest market during the forecast period. In 2016, Japan is the major market in Asia-Pacific, whereas in Europe, Germany generates highest revenue in this market.

Browse Report Sample at: http://bit.ly/2oKvgEn

Technological advancement is leading to the product innovation

The research states that the manufacturers in the needle-free diabetes management market are focusing continually on workflow enhancements and improving diabetes management and device performance. Currently, the healthcare cost is outpacing the government expenditure on healthcare. The development of technologically advanced diabetes management devices has become necessary to ensure increased healthcare efficiency and productivity. Some of the key players in the global market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Inovio Pharmaceuticals, Inc., Pharmajet, Inc., Zogenix, Inc., Antares Pharma Inc., and Glide Pharmaceutical Technologies Ltd.

Vascular Imaging Systems Market Analysis, Size, Development and Demand Forecast to 2023

The global vascular imaging systems market is expected to grow at a CAGR of 5.7%, during 2017 - 2023.

Increasing healthcare expenditure drives the global market

According to the study, the global vascular imaging systems market is likely to grow significantly, during the forecast period, due to increasing healthcare expenditure, increasing prevalence of cancer and cardiovascular diseases and rising awareness about imaging techniques due to various conferences and seminars. In addition, growing geriatric population and launch of technologically advanced products contribute to the growth of the market. High cost, stringent regulatory requirements, shortage of helium for magnetic resonance imaging and increasing risk of cancer due to exposure to radiations are the key factors restraining the global market growth.

Browse Report Overview at: http://bit.ly/2o7bW82

North America stands as the largest vascular imaging systems market

Geographically, North America has been the largest market for vascular imaging systems, where the U.S. has been the largest contributor to the regional market. Increasing awareness about imaging techniques has been driving the growth of the North American market. In Europe, Germany has been the largest contributor to the market, followed by the U.K. and France. Asia-Pacific market is expected to grow at the highest CAGR, during 2017 - 2023, owing to increasing prevalence of cancer and cardiovascular diseases.

Increasing prevalence of cardiovascular diseases and cancer supports the market growth

The factors driving the growth of the market include increasing prevalence of cardiovascular diseases and cancer and aging population. According to the International Agency for Research on Cancer (IARC), a specialized cancer agency of World Health Organization (WHO) that promotes cancer research, in 2008, 12.7 million new patients were detected with cancer globally, and the number is expected to reach 21.4 million by 2030. In addition, according to WHO, 8.2 million deaths took place in 2012, globally, due to cancer, out of which 1.6 million deaths were due to lung cancer, while the reason for 745,000 deaths was liver cancer and 400,000 deaths occurred due to esophageal cancer.

According to the Conference of Radiation Control Program Directors, Inc. (CRCPD), around 62 million CT procedures are performed every year in the U.S. including 4 million CT procedures performed for children. Moreover, according to the European Association of Nuclear Medicine (EANM) annual congress, the number of patients in Western Europe undergoing PET procedures increased by 21% between 2005 and 2010, accounting for 900,000 procedures in 2011. The rapidly increasing demand for vascular imaging procedures drives the growth of the market.

Explore Report Sample at: http://bit.ly/2pgkxEK

Key players in the vascular imaging systems market

Some of the key players in the global market include Siemens AG, General Electric Company, Hitachi Ltd., and Koninklijke Philips N.V., Carestream Health, Inc., Hologic, Inc., Esaote S.P.A, Shimazdu Corporation, Canon Inc., Orthoscan, Inc., and Fujifilm Corporation.

Monday, April 17, 2017

Animal Healthcare Market Size, Development, Growth and Demand Forecast to 2022


The global animal healthcare market is expected to grow from $29,537.4 at a CAGR of 7.0% during 2016-2022. Among the various products, the pharmaceuticals segment including, ectoparasiticides, endoparasiticides, anti-inflammatories and others accounted for largest share in the global animal healthcare market in 2015.

Explore Full Report at:  http://bit.ly/2ohubn6

The increasing population of production animals and companion animals is supporting the growth of the global animal healthcare market. The production animals are nurtured by the consumers for milk and meat related products; whereas, companion animals are adopted for office or house guards and companionship.

The increasing transfer of diseases from animals to humans, through companionship and consumption of products sourced from them, are driving the demand of the global animal healthcare market. Legislations and protest of animal institutions and activists, and excess use of antibiotics in production animals are some of the factors restraining the growth of the animal healthcare market. Most of the animal healthcare companies are concentrating on research and development activities to offer better vaccine and pharmaceutical products for the prevailing diseases. The top ten competitors in the global animal healthcare market accounts for 75% of the total market share, which creates more competition in the market.

Explore Report Sample at: http://bit.ly/2olwwwR

The growing population, increasing per-capita income level, and changing lifestyle of the consumers are some of the factors leading to increased meat consumption globally. Due to the growing health concern of animals and their increasing number, the healthcare expenses in farms are surging globally. Animal farms are increasing globally, due to growing demand for protein rich foods, such as milk, eggs, and meat.

Some of the major companies operating in the global animal healthcare market include Zoetis, Merck, Merial, Bayer, Virbac, Ceva Sante Animal S.A., Boehringer Ingelheim GmbH, Elanco, and Vetoquinol.

Thursday, April 13, 2017

Mexico Cards and Payments Market Size, Development, Growth and Forecast to 2020

The research report provides in depth analysis and insights into the Mexican Cards and Payments Market including, strategies deployed by banks to market debit and credit cards and competitive landscape (card issuers in the country) for both debit cards and credit cards. The study includes 3 years historical market size and 6 years market forecast in terms of number of cards, value and volume of transactions processed through these cards, and other key metrics. The report also provides information on the key industry trends, major schemes, banks and detailed segmentation of card and payment industry. The research report is a new offering from the company’s Financial Services domain, and leveraged from the company’s existing cards and payments database of 50+ countries.
Explore Report with Detailed TOC onMexico Cards and Payments Market” at: https://www.psmarketresearch.com/market-analysis/mexico-cards-and-payments-market

The total number of cards in circulation reached 166.5 million by the end of 2014, whereas the total population of the country reached 119.5 million, representing a penetration of 1.4 cards per person in 2014. In terms of number of cards in circulation, the Mexican payment cards market is expected to grow at a CAGR of 4.7% over the period 2015-2020. The growth of the card payments market will be driven by the growth of e-commerce, higher disposable income per capita, new product offerings and growth in retail.

In Mexico, the debit cards dominate the payment cards market in terms of number of cards in circulation. Debit cards accounted for 81% of the total number of cards in circulation in 2014. Debit cards are being used by consumers to shop at retail outlets, withdraw cash from ATMs and make online payments. Some of the key players in the debit cards market include BBVA Bancomer, Banamex-Citibank, Banorte, Banco Santander, Scotiabank. BBVA Bancomer was the leading bank in terms of number of debit cards issued in 2014.

The total number of credit cards in Mexico increased at a CAGR of 6.1% during the period 2012-2014. However during the forecast period, the growth is expected to slow down to a CAGR of 4.8%. The average credit card transaction value in Mexico increased from MXN 861.3 in 2012 to MXN 875.6 in 2014, at a CAGR of 0.8%. The average transaction value is expected to grow at a CAGR of 1.2% during the forecast period.


Luis Miguel Torre, Executive Consumer Credit Director of Banamex, said: “This launch in Mexico represents a very important step for the Citi strategy that pursues the alignment of products and programs in scale economies, always thinking of a standardized experience for our customers that has been proven and is supported worldwide.”

Luis Miguel Torre, Executive Consumer Credit Director of Banamex, said: “This launch in Mexico represents a very important step for the Citi strategy that pursues the alignment of products and programs in scale economies, always thinking of a standardized experience for our customers that has been proven and is supported worldwide.”

Malaysia Cards and Payments Market Size, Share, Growth and Demand Forecast to 2020

The research report provides in depth analysis and insights into the Malaysia Cards and Payments Market including, strategies deployed by banks to market debit and credit cards and competitive landscape (card issuers in the country) for both debit cards and credit cards. The study includes 3 years historical market size and 6 years market forecast in terms of number of cards, value and volume of transactions processed through these cards, and other key metrics. The report also provides information on the key industry trends, major schemes, banks and detailed segmentation of card and payment industry. The research report is a new offering from the company’s Financial Services domain, and leveraged from the company’s existing cards and payments database of 50+ countries.

Explore Report with Detailed TOC on “Malaysia Cards and Payments Market” at: https://www.psmarketresearch.com/market-analysis/malaysia-cards-and-payments-market


In Malaysia, debit cards dominate the payment card market in terms of number of cards in circulation. In 2014, the debit cards accounted for 83.3% of the total number of cards in circulation. Debit card penetration per 100 inhabitants reached from 129 in 2012 to 135 in 2014. Key players in the debit cards market include Maybank, Bank Simpanan Nasional, Public bank Berhad, CIMB, Hong Leong Bank etc. Maybank was the leading bank in terms of number of debit cards issued in 2014.

Some of the key players in the credit card market in the Malaysian card payments include Citibank, Maybank, Hong Leong Bank, HSBC, CIMB and AmBank.

The use of non-cash retail payments continued to grow with the average number of non-cash transactions per capita increasing to 88 in 2015, compared to 55 transactions in 2011. The most common non-cash payments were e-money transactions, mainly transit payments using prepaid cards. This was followed by credit transfers and payment card transactions. In contrast, the use of cheques continued to decline, with the number of cheques issued per capita falling from 7 cheques in 2012 to 5 cheques in 2015.


In April 2015, Bank Negara Malaysia launched a national electronic bill payment platform “JomPAY”. It allows customers of a participating bank to make payments to the registered billers of all JomPAY participating banks. This platform eliminates the need for a biller to maintain banking relationships with multiple banks in order to accept payments from its customers. As of 2015, JomPAY is offered by 29 banks through online banking and 4 banks via ATMs, with 472 registered billers accepting payments through the platform. Bank Negara Malaysia plans to include new small and medium enterprises and micro enterprises, with a target of 5,000 registered billers by the year 2020.

Wednesday, April 12, 2017

Canada Cards and Payments Market Size, Development, Growth and Forecast to 2020

The research report provides in depth analysis and insights into the Canada Cards and Payments Market including, strategies deployed by banks to market debit and credit cards and competitive landscape (card issuers in the country) for both debit cards and credit cards. The study includes 3 years historical market size and 6 years market forecast in terms of number of cards, value and volume of transactions processed through these cards, and other key metrics. The report also provides information on the key industry trends, major schemes, banks and detailed segmentation of card and payment industry. The research report is a new offering from the company’s Financial Services domain, and leveraged from the company’s existing cards and payments database of 50+ countries.

The number of payment cards in circulation in Canada increased at a CAGR of 6.1% during the period 2012-2014. The growth of cards in circulation during the period can be attributed to expansion of ATMs and POS terminals, growing disposable income and greater acceptance of payment cards in the country.
The consumer preference for cashless payments further supports the growth of card payments in the country. Banks have implemented different pricing and marketing strategies to encourage consumers to increase card payments rather than paying in cash. Common strategies used by banks and card issuers are product discounts and reward points.

The Canadian payment card market is dominated by the credit card segment, in terms of number of cards in circulation. Credit cards are being used by consumers to shop at retail outlets and make online payments. The credit card market is expected to grow over the forecast period at a CAGR of 1.6%. MasterCard was the leading scheme in the credit card market in 2014. The credit cards in the country were primarily used at POS terminals for retail purchases, rather than for cash withdrawals at ATMs. The frequency of credit card use witnessed a CAGR of 1% during 2012-2014. The credit card market witnessed intense competition among credit card issuers, to encourage card usage and spend. The card issuing banks implemented various marketing strategies and offered numerous campaigns to attract consumers. The key players in the credit card market include Royal Bank of Canada, TD Canada Trust, Canadian Imperial Bank of Commerce and Bank of Montreal.


The charge cards segment represents a small portion of the Canadian pay later card market. Average charge card transaction value declined from CAD 121.4 in 2012 to CAD 117.7 in 2014, at a CAGR of -1.5%. The average charge card transaction value is further expected to decline during the forecast period.

Brazil Cards and Payments Market Size, Development, Growth and Forecast to 2020

The research report provides in depth analysis and insights into the Brazil Cards and Payments Market including, strategies deployed by banks to market debit and credit cards and competitive landscape (card issuers in the country) for both debit cards and credit cards. The study includes 3 years historical market size and 6 years market forecast in terms of number of cards, value and volume of transactions processed through these cards, and other key metrics. The report also provides information on the key industry trends, major schemes, banks and detailed segmentation of card and payment industry. The research report is a new offering from the company’s Financial Services domain, and leveraged from the company’s existing cards and payments database of 50+ countries.

In terms of number of cards in circulation, the Brazilian payment cards market grew at a CAGR of 6.5% during the period 2012-2014 and it is expected to further grow over the forecast period, but at a slower pace. The growth of the Brazilian card payments market will be driven by growing disposable income, growth of retail sector, an increasing market for mobile commerce and greater acceptance of payment cards in the country. Brazil population grew from 199.2 million in 2012 to 202.7 million in 2014, and is expected to reach 210.8 million by 2020. This increase in population is expected to encourage card spending over the forecast period.

The debit cards dominated the Brazilian card payments market in terms of number of cards in circulation. Average debit card transaction value increased from BRL 159.8 in 2012 to BRL 170.2 in 2014, at a CAGR of 3.2%. The average transaction value is anticipated to grow at a CAGR of 0.9% during the period 2015-2020. Some of the key players in the debit cards market include Banco do Brasil, Caixa Econômica Federal, Banco Bradesco, Banco Santander, and Itau Unibanco. Caixa Econômica Federal was the leading bank in terms of number of debit cards issued in 2014.



In December 2015, Morpho announced the production of smart card modules for “Elo”, a 100% Brazilian payment association set up by Bradesco, Banco do Brasil and CAIXA. Morpho created a smart card operating system for the Brazilian company, allowing every smart card to be used for banking applications as well as for shopping with credit and debit functions, accepted at more than 1.7 million point of sales terminals and establishments.

Monday, April 10, 2017

Automotive Composite Market Size, Development and Demand Forecast to 2022

The automotive composite market is driven by increasing demand for lightweight and fuel-efficient vehicles, increasing per capita vehicle ownership, increasing automotive production, especially in Asia-Pacific, and strict government regulations to reduce carbon emission from vehicles.
The implementation of stringent environmental regulations across the globe is propelling the demand for lightweight materials. Several international organizations are framing strict guidelines and standards to reduce the greenhouse gases emission. In 2011, global CO2 emission stood at 31.6 gigatons, with 23% of these emissions coming from all transport sectors across the globe. According to the Corporate Average Fuel Economy regulations, all vehicles plying in the U.S. need to have average fuel efficiency of 54.5 miles per gallon by 2025. As per the European government CO2 emission regulation, the total CO2 emission from new passenger cars should be decreased from 130g per Km travel in 2013 to 95g per Km travel by 2020. According to Germany based SuperLight-Car, about one-third of total fuel consumption by passenger car depends on weight. For instance, weight reduction up to 100 kg is expected to save 0.3 liters to 0.5 liters of fuel for every 100 km drive. Also, with reduced weight of vehicle, CO2 emissions can be minimized, if not completely removed. The overall weight of vehicles can be reduced by using advanced multi-materials, which is a combination of steel, aluminum, magnesium, plastics, and composites. This is further expected to provide ample growth opportunity for the composites market in the automotive industry.

In Europe, Germany, France, U.K., Russia and Spain were the major automotive composite markets in 2015. The European OEMs account for more than one third of the global light vehicle production. With various development initiatives going on, Europe was ranked second in vehicle development in 2015 and is expected to remain at the same position during the forecast period. The European automotive industry is at the forefront in terms of technological advancements. It is focusing on the lightweight technologies and enhancing passenger comfort.
North America is expected to be the third largest region for automotive composite market during the forecast period owing to its increasing customer base and high disposable incomes in the region. This has resulted in increased manufacturing activities by local automotive OEMs in the region, and supporting the growth of the automotive composite market.
Some of the major competitors in the global automotive composite market include Toray Industries, Inc., Koninklijke Ten Cate N.V., SAERTEX GmbH & Co. KG, Cytec Industries Inc., Scott Bader Company Ltd., Teijin Limited, UFP Technologies, Inc., E.I. du Pont de Nemours and Company, Johnson Controls Inc., and Johns Manville.

Tuesday, April 4, 2017

Medical Aesthetics Market Analysis, Size, Development and Forecast to 2023


The global medical aesthetics market is projected to reach $19,419.7 million by 2023, growing at a CAGR of 12.2% during 2017 - 2023.

Global medical aesthetics market worth $8,629.9 million in 2016

According to the study, the global medical aesthetics market is likely to grow from $8.6 billion in 2016 to $19.4 billion by 2023. Advancement in laser technology, growing awareness among consumers, and health benefits of medical aesthetics procedures have been driving the global medical aesthetics market. The market is further expected to gain revenue due to shift in the preference from surgical to non-surgical procedures. There has been a significant growth in non-surgical medical spa procedures in the recent years, resulting from better technologies, such as intense pulsed light and advanced laser based aesthetics equipment.


Insights on market segments

As per the findings of research, injectables held the largest share in the global market in 2016, primarily due to high sales of botulinum toxin. Topicals, the second largest medical aesthetics product segment, witnessed the highest growth during 2013 – 2016. The highest growth of topicals is attributed to their ability to treat several skin conditions without any usage of uncomfortable procedures. Beauty clinics and centers was the largest end user of the global medical aesthetics market in 2016., followed by spas and salons.

North America stands as the largest medical aesthetics market

Geographically, North America has been the largest market for medical aesthetics, with the U.S. being the largest contributor to the regional market. North America is considered as the platform for innovation in aesthetics procedures, since a majority of established and upcoming market players are either headquartered or have a significant geographical presence in the region. The emerging economies of Asia-Pacific, especially China and India, are expected to grow tremendously in future, which will make Asia-Pacific the second largest market in the coming years. Asia-Pacific is expected to outpace Europe in in terms of medical aesthetics market size by 2020.



Key players in the medical aesthetics market actively seeking acquisitions

The medical aesthetics market has witnessed number of mergers and acquisitions and strategic alliances recently. In December 2016, Allergan Plc. acquired LifeCell, a medicine company of Acelity L.P. Inc., for a cash consideration of $2.9 billion. The acquisition is expected to combine LifeCell’s business of regenerative medicines with Allergan’s medical aesthetics business. Allergan aims to strengthen its presence in regenerative medicine business with this acquisition. In April 2016, the company also acquired Topokine Therapeutics, a private company developing topical medicines for fat reduction, for a total consideration of $85.0 million. Topokine Therapeutics’ XAF5 is in late-stage development for the treatment of steatoblepharon.

Some of the other key players in the market include Allergan Plc, Valeant Pharmaceuticals International, Inc., ZELTIQ Aesthetics, Inc., Johnson & Johnson, Cutera Inc., Alma Lasers Ltd., Merz GmbH & Co. KGaA, Galderma S.A., Syneron Medical Ltd., Cynosure, Inc., Photomedex, Inc. and Lumenis Ltd.

Anti-Counterfeit Packaging Market Trends, Demand, Growth, Revenue Forecast by 2023

Global  anti-counterfeit packaging market  is projected to reach $208.4 billion by 2023. Growth of the counterfeit industry and increasing ...